Zurcher Kantonalbank (Zurich Cantonalbank) Gamida Cell Ltd. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

  • $28 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 21, 2022
SELL
$2.22 - $4.47 $13,659 - $27,503
-6,153 Closed
0 $0
Q4 2021

Feb 01, 2022
SELL
$2.2 - $4.46 $1,399 - $2,836
-636 Reduced 9.37%
6,153 $16,000
Q3 2021

Nov 15, 2021
BUY
$3.85 - $6.44 $207 - $347
54 Added 0.8%
6,789 $27,000
Q2 2021

Jul 30, 2021
BUY
$5.85 - $8.33 $3,182 - $4,531
544 Added 8.79%
6,735 $43,000
Q1 2021

May 03, 2021
BUY
$7.8 - $12.43 $48,289 - $76,954
6,191 New
6,191 $50,000

Others Institutions Holding GMDA

# of Institutions
58
Shares Held
11.4M
Call Options Held
235K
Put Options Held
70.5K
View Full List

About Gamida Cell Ltd.

GMDA Quotes by TradingView
  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email